Proteomic insights into paediatric cancer: Unravelling molecular signatures and therapeutic opportunities
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Proteomics offers new hope for treating difficult childhood cancers. By analyzing proteins, researchers can find novel biomarkers and develop targeted therapies to improve survival rates for pediatric cancer patients.
Area Of Science
- Oncology
- Biochemistry
- Genomics
Background
- Paediatric cancer survival has improved due to molecular signatures and risk-directed therapies.
- Some childhood cancers remain challenging to treat, necessitating novel biomarker discovery.
- Proteins, the drivers of cellular function and drug targets, are key to understanding cancer.
Purpose Of The Study
- To review the current state of proteomic analyses in paediatric cancer.
- To highlight opportunities and challenges in applying proteomics to childhood cancers.
- To emphasize the potential of proteomics in advancing paediatric precision medicine.
Main Methods
- Focus on mass spectrometry (MS)-based proteomic approaches.
- Review of discoveries and applications of proteomics in paediatric cancer research.
- Analysis of the dynamic nature of the proteome compared to the genome.
Main Results
- Proteomics provides insights into cellular phenotypes and potential drug targets.
- MS-based proteomics is a powerful tool for identifying cancer biomarkers.
- The proteome's dynamism offers unique advantages over genomic analysis in cancer research.
Conclusions
- Proteomic analyses hold significant promise for paediatric cancer research.
- Integrating proteomics into paediatric precision medicine can improve patient outcomes.
- Further research and application of proteomics are crucial for overcoming treatment-resistant childhood cancers.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...